Article Details
Retrieved on: 2023-11-16 14:37:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Analysts have lowered Q4 earnings projections at an above-average rate in October, largely due to guidance cuts from Pfizer (PFE) and Merck (MRK).
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here